Genetic Technologies Limited · ASX:GTG
Genetic Technologies — Shareholder Meeting (December 2020)
13 slides from Genetic Technologies's shareholder meeting presentation, Dec 10, 2020
Slide 1: AGM Presentation
For personal use only Authorised by George Muchnicki (CEO) Genetic based preventative 60-66 , 3065 health platform : +61 3 8412 7000 Personalised, Precision medicine. AGM Presentation December 10th 2020 Coming soon
Slide 2: Notice: Forward looking statements
Notice: Forward looking statements For personal use only The purpose of the presentation is to provide an update of the business of Genetic Technologies Limited ACN: 009 212 328 (ASX:GTG; NASDAQ:GENE). These slides have been prepared as a presentation aid only and the information they contain may re
Slide 3: Our Board
For personal use only Our Board 3
Slide 4: Genetic Technologies - Leader in Genomics
Genetic Technologies - Leader in Genomics For personal use only F Over a decade developing polygenic risk scores - for major oncological, metabolic and degenerative diseases F Strong scientific leadership under Dr Richard Allman – a pioneer in the development of polygenic risk scores F Academic coll
Slide 5: Products & Pipelines
Products & Pipelines For personal use only CR Cancer Breast Cancer BRCA Panel Lynch Syndrome Prostate Diabetes CVD Melanoma Depression COVID-19 5
Slide 6: COVID-19 SDR (Serious disease risk)
COVID-19 SDR (Serious disease risk) For personal use only World first genetic risk test that predicts your risk of hospitalisation & life threatening complications Genetype for COVID-19 SDR Indication F World first F Able to identify who is: F Combines genetic risk with clinical risk - at risk of se
Slide 7: Genetic Testing & Reimbursement
GENETIC TESTING & REIMBURSEMENT For personal use only Germline Testing (BRCA/Lynch Syndrome) F Inherited genes validated technology associated with high incidence of cancer risk F reimburable both in the US and Australia F NGS Sequencing - is increasingly used in medical management of patients and t
Slide 8: Genetype for Mental Health
Genetype for Mental Health For personal use only Powered by Taliaz’s Predictix platform Utilising a combination of: genetic, metabolic, clinical & demographic background data in conjuction with AI & ML to create diagnostic and pharmacogenetic solutions that are 47% better than current best in class
Slide 9: Expansion/Growth/Market Size
Expansion/Growth/Market Size For personal use only ONCOLOGY Lifestyle Ancestry BC, CRC, PC, /Microbiome Melanoma GENETIC TECHNOLOGIES CVD (Genetype) Pharmoco- (Heart Disease) genetics IHD, AF Mental Metabolic Health Diseases (by Taliaz) Diabetes Germline COVID-19 Testing SDR (BRCA, Lynch Syndrome) P
Slide 10: Sales & Distribution by Region and Method
For personal use only SALES & DISTRIBUTION SALES & DISTRIBUTION by Region by Method • Certified by US regulators CLIA to sell into • CIT (Consumer initiated testing and online sales the USA and marketing platform with medical supervision) launched in Australia & the USA in • Certified by Australian
Slide 11: Corporate
Corporate For personal use only • Dual listed on ASX and the Nasdaq the worlds largest biotech exchange Listings In 2001 and 2005 respectively • 600 shares on the ASX equate to 1 ADR (American Depository Receipts) in the USA which are interchangeable via custodian bank of Mellon with 70% of stock he
Slide 12: Progress over the year
Progress over the year For personal use only 1Q 2020 Launched CIT Australia 2Q 2020 Colorectal Cancer COVID-19 sdr test Market Release Pivoted and established the test 3Q 2020 with target release this month COVID-19 risk of hospitalisation 4Q 2020 Test prototype Cardiovascular Prototype 1H 2021 Type
Slide 13: The next months
The next 12 months For personal use only Complete development of high density multi disease tests to: • Provide coverage of >70% mortality causes in western society using a single swab • Delivering low cost, accurate risk data Establishing new divisions: • Oncology • Metabolic Diseases • Cardiovascu
Genetic Technologies — Shareholder Meeting (December 2020) on 6ix